.jpeg?token=b3f7843d82b66067e2db74c657515cfc)
Acurx Pharmaceuticals, LLC.
.png?token=50254ca7cffdeab1a303bed2ccc8ca74)
Drug Discovery
Acurx is a privately-held clinical-stage biopharmaceutical company focused on developing a new class of antibiotics that address difficult to treat bacterial infections.
Cantilever holds equity interests plus warrants on the company.